10-Q: Fortive Reports Q1 2026 Results: Sales Up 7.7%, Profitability Improves
Quarterly Report
Fortive Corporation announced its first quarter 2026 financial results, with total sales increasing by 7.7% year-over-year to $1,069.4 million, driven by core revenue growth and improved operating profit margins.
Summary
- Fortive Corporation reported total sales of $1,069.4 million for the first quarter ended April 3, 2026, a 7.7% increase compared to $993.1 million in the same period of 2025.
- Net earnings for the quarter were $136.4 million, or $0.44 per diluted share, compared to $171.9 million, or $0.50 per diluted share, in the prior year period.
- The Intelligent Operating Solutions (IOS) segment generated $743.2 million in sales, while the Advanced Healthcare Solutions (AHS) segment reported $326.2 million in sales.
- Operating profit margin improved to 17.9% from 16.6% in the prior year quarter, driven by pricing, volume, and productivity measures.
- The company repurchased 8.9 million shares of common stock for approximately $500 million during the quarter.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive report, with strong top-line growth and improved operating margins, although a slight decrease in net earnings was noted due to the prior year's discontinued operations.
Positives
- Total sales increased by 7.7% to $1,069.4 million, driven by core revenue growth of 5.3%.
- Operating profit margin improved by 130 basis points to 17.9% compared to the prior year quarter.
- Intelligent Operating Solutions (IOS) segment sales grew 7.6% year-over-year.
- Advanced Healthcare Solutions (AHS) segment sales grew 7.9% year-over-year.
- Favorable pricing contributed 2.2% to overall sales growth.
- Volume growth contributed 3.1% to overall sales growth.
- The company maintained a strong liquidity position with $356.1 million in cash and equivalents.
- The revolving credit facility remains undrawn, indicating strong financial flexibility.
Negatives
- Net earnings decreased to $136.4 million from $171.9 million in the prior year period.
- Diluted earnings per share decreased to $0.44 from $0.50 in the prior year period.
- Gross profit margin slightly decreased to 63.2% from 64.2% in the prior year period.
- Selling, general, and administrative (SG&A) expenses as a percentage of sales increased to 39.0% from 41.1% in the prior year period.
Risks
- Conditions in the global economy, markets served, and financial markets may adversely affect business and financial results.
- Inability to adjust manufacturing capacity, supply chain management, or purchases to reflect market changes could harm profitability.
- Reliance on sole or limited sources of supply for certain materials, components, and services could cause production interruptions.
- Fluctuations in the cost and availability of commodities or components used in operations.
- Market declines, slower-than-anticipated growth, or cyclicality in markets served could hinder growth.
- Intense competition may lead to decreased demand, market share loss, or price reductions.
- Dependence on timely development and commercialization of new products and services.
- Challenges in managing leadership transitions and retaining key employees.
- Disruptions or security breaches in information technology systems, including cyberattacks.
- Product defects, unanticipated use, or inadequate disclosure could harm business, reputation, and financial results.
- Adverse changes in relationships with key distributors or channel partners.
- Work stoppages, labor disputes, or other labor issues could impact productivity.
- Loss of facilities, supply chains, distribution systems, or IT systems due to catastrophe.
- Failure to adequately protect intellectual property or infringement by third parties.
- Claims of infringing or misappropriating third-party intellectual property.
- Restructuring activities could have long-term adverse effects.
- Litigation and legal/regulatory proceedings could adversely affect financial results.
- Climate change or measures to address it may negatively affect the company.
- Challenges with the use of artificial intelligence could lead to reputational harm, competitive harm, and legal liability.
- International economic, political, legal, compliance, and business factors, including geopolitical conflicts, could negatively affect financial results.
- Volatile trade relations between the U.S. and other countries.
- Foreign currency exchange rate volatility.
- Execution and delivery of disciplined capital allocation is critical.
- Acquisitions, investments, joint ventures, and strategic relationships could negatively impact financial results.
- Indemnification provisions in acquisition agreements may not fully protect against unexpected liabilities.
- Divestitures could negatively impact the business, and contingent liabilities from sold businesses could be adverse.
- Potential indemnification liabilities to Ralliant and Vontier could materially and adversely affect the business.
- Changes in industry standards and governmental regulations may reduce demand or increase expenses.
- Improper conduct by employees, agents, or business partners could impair reputation and ability to do business.
- Environmental, health, and safety liabilities, costs, and violations.
- Failure to comply with extensive regulations, including healthcare regulations.
- Changes in effective tax rates or exposure to additional tax liabilities.
- Audits by tax authorities could result in additional tax payments.
- Potential for separation transactions to be determined as taxable.
- Changes in U.S. GAAP could adversely affect reported financial results.
- Potential impairment charges for goodwill and other intangible assets.
- Significant debt obligations and the cost of debt.
- Downgrades in credit rating could increase borrowing costs and limit access to capital markets.
Future Outlook
The company expects its operating cash flow and other sources of liquidity to be sufficient to fund existing businesses, strategic acquisitions, separations, stock repurchases, debt payments, and contractual obligations. Access to commercial paper and capital markets is subject to credit ratings and market conditions. The company continues to monitor financial markets, bank stability, and global economic conditions.
Management Comments
- Fortive Corporation innovates essential technologies to keep our world safe and productive.
- Management believes that reporting the non-GAAP financial measure of core revenue provides useful information to investors by helping identify underlying growth trends in our business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers.
- Management believes that the exclusion of the effect of acquisitions and divestitures and currency translation may facilitate the assessment of underlying business trends and may assist in comparisons of long-term performance.
Industry Context
StockSavvy.ai notes that Fortive's performance in Q1 2026, with a 7.7% sales increase and improved operating margins, aligns with a broader trend of industrial technology companies benefiting from pricing power and demand in specialized segments like Intelligent Operating Solutions and Advanced Healthcare Solutions, despite some macroeconomic headwinds.
Comparison to Industry Standards
- While specific comparable companies are not detailed in the filing, Fortive's reported core revenue growth of 5.3% for Q1 2026 is a solid performance in the industrial technology sector, which has seen varied growth rates among peers due to differing end-market exposures and product cycles.
- The improvement in operating profit margin to 17.9% suggests effective cost management and pricing strategies, which is a positive indicator when compared to industry benchmarks that often face margin pressure from supply chain costs and inflation.
- Fortive's focus on two distinct segments, IOS and AHS, allows for targeted strategies. Competitors in the IOS space, such as Honeywell or Emerson Electric, also focus on industrial automation and software, while AHS competitors like Stryker or Medtronic operate in specialized healthcare technology markets. Fortive's ability to grow both segments indicates a diversified strength.
- The company's active share repurchase program, with $500 million in buybacks in Q1 2026, is a common capital allocation strategy among large-cap industrial firms, aiming to return value to shareholders and potentially boost EPS.
Legal Proceedings
- The company is subject to a variety of litigation and other legal and regulatory proceedings in the course of its business that could adversely affect its financial results.
Related Party Transactions
- Amounts paid and received by Fortive for transition services provided to Ralliant, as well as sales and purchases to and from Ralliant, were not material to the Company's results of operations during the three months ended April 3, 2026.
- Receivables from Ralliant related to the tax matters agreement and pass-through arrangements were $4.8 million as of April 3, 2026, down from $20.8 million as of December 31, 2025.
Stakeholder Impact
- Shareholders: Benefit from improved operating margins and continued share repurchases, though net earnings per share saw a slight decline compared to the prior year's period which included discontinued operations.
- Employees: May experience impacts from ongoing restructuring plans and investments in innovation and commercial initiatives.
- Creditors: The company's strong liquidity position and compliance with debt covenants provide assurance.
- Suppliers: May be affected by fluctuations in commodity and component costs, and the company's efforts to manage supply chain and production.
Next Steps
- Continue to monitor financial markets, bank stability, and global economic conditions.
- Manage capital structure on a short and long-term basis.
- Continue to deploy the Fortive Business System (FBS) to manage challenges and offset dynamics.
- Potentially utilize the option to extend the Revolving Credit Facility by one year, twice.
Key Dates
| Date | Description |
|---|---|
| 2022-02-28 | Adoption of General Share Repurchase Program. |
| 2025-03-28 | Comparable period for Q1 2026 results (Three Months Ended March 28, 2025). |
| 2025-12-31 | Previous fiscal year end. |
| 2026-01-01 | Beginning of the fiscal quarter ended April 3, 2026. |
| 2026-03-17 | Third Amended and Restated Credit Agreement entered into, extending Revolving Credit Facility to March 17, 2031. |
| 2026-04-03 | End of the quarterly period for the report. |
| 2026-04-30 | Date of signatures for the report. |
Recommendation
holdThe company demonstrates solid revenue growth and margin expansion, indicating operational strength. However, the decrease in net earnings and EPS compared to the prior year (even when accounting for discontinued operations) and the ongoing risks associated with global economic conditions and competition warrant a cautious 'hold' stance. Further clarity on the impact of restructuring and future growth drivers would be needed for a stronger recommendation.
Keywords
Fortive Corporation, 10-Q, Quarterly Report, Financial Results, Intelligent Operating Solutions, Advanced Healthcare Solutions, Sales Growth, Operating Profit, Earnings Per Share, Share Repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.